PM
ZYME icon

Prosight Management’s Zymeworks ZYME Stock Holding History

Prosight Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.5M Buy
539,049
+8,656
+2% +$205K 2.21% 15
2025
Q4 		$14M Sell
530,393
-219,218
-29% -$4.78M 2.89% 16
2025
Q3 		$12.8M Sell
749,611
-560,293
-43% -$8.02M 2.99% 15
2025
Q2 		$16.4M Buy
1,309,904
+352,675
+37% +$4.2M 4.01% 10
2025
Q1 		$11.4M Buy
957,229
+137,229
+17% +$1.87M 3.75% 9
2024
Q4 		$12M Sell
820,000
-97,599
-11% -$1.36M 3.32% 13
2024
Q3 		$11.5M Sell
917,599
-262,401
-22% -$2.86M 2.83% 13
2024
Q2 		$10M Buy
1,180,000
+769,052
+187% +$6.85M 3% 13
2024
Q1 		$4.32M Buy
+410,948
New +$4.56M 1.2% 22
2023
Q4 		– Sell
-106,405
Closed -$675K – 47
2023
Q3 		$675K Buy
+106,405
New +$786K 0.21% 39

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Prosight Management's ZYME Position: Q1 2026 in Review

Prosight Management increased its Zymeworks (ZYME) stake by 1.6% in Q1 2026, buying an estimated $205K and bringing the position to 539,049 shares worth $13.5M. The position accounts for 2.21% of the portfolio, ranked #15.

Prosight Management first reported a position in ZYME in Q3 2023 and has held it in 10 quarters since. The position peaked at $16.4M in Q2 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Prosight Management held 539,049 shares of Zymeworks worth $13.5M as of Q1 2026.
  • Prosight Management bought 8,656 Zymeworks shares in Q1 2026, an estimated $205K.
  • Zymeworks made up 2.21% of Prosight Management's portfolio in Q1 2026, its #15 holding.
  • Prosight Management first reported a position in Zymeworks in Q3 2023 and has held it in 10 quarters since.
  • Prosight Management's Zymeworks position peaked at $16.4M in Q2 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Prosight Management's 13F filing for Q1 2026, filed 15 May 2026.